• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Pharmaceutical Economics and Policy

Pharmaceutical Economics and Policy

9780195300956
519,48 zł
467,53 zł Zniżka 51,95 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 467,53 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholdervalue, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nations healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of thepharmaceutical industry, from both an American and worldwide perspective. This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated. In addition, the book includes six new chapters on emerging topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often called nutraceuticals. Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatientdrugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care.
Szczegóły produktu
OUP USA
85867
9780195300956
9780195300956

Opis

Rok wydania
2006
Numer wydania
2
Oprawa
twarda
Liczba stron
352
Wymiary (mm)
165 x 242
Waga (g)
630
  • Introduction; Part I. The Industry; The Pharmaceutical Industry; The Biotechnology Industry; Other Firms in the Pharmaceutical Industry; Marketing Pharmaceuticals; Part II. The Consumer; The Demand for Pharmaceuticals; Part III. The Market; Pharmaceutical Prices; The Worldwide Market for Pharmaceuticals; Pricing Pharmaceuticals in a World Environment; The Timing of Drug Approvals in the United States and Abroad; Part IV. Intervention in the Pharmaceutical Market: Public and Private; Pharmaceutical Regulation and Cost Containment by the Public Sector; Regulation by the Private Sector; Pharmaceutical Regulation in Europe; Patent Protection; Evaluating New Drugs; Complementary and Alternative Medicines; Pharmaceuticals and Health Policy: A Look Ahead;
Komentarze (0)